Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes

Endocrine Journal

Volumn 62, Issue 5, 2015, Pages 417-421

  Yamada, Hodaka ^a   Saito, Tomoyuki ^a   Aoki, Atsushi ^a   Asano, Tomoko ^a   Yoshida, Masashi ^a   Ikoma, Aki ^a   Kusaka, Ikuyo ^a   Toyoshima, Hideo ^a   Kakei, Masafumi ^a   Ishikawa, San E ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Beta cells proliferation; Betatrophin; Insulin resistance; Lipid metabolism

Indexed keywords

BETATROPHIN; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; AGED; ANALYSIS; BLOOD; DIET RESTRICTION; JAPAN; MIDDLE AGED;

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MALE; MIDDLE AGED; PEPTIDE HORMONES; TRIGLYCERIDES;

EID: 84933502107     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0525     Document Type: Article

References (23)

1. Vetere A, Choudhary A, Burns SM, Wagner BK (2014) Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug Discov 13:278-289.
2. Seymour PA, Serup P (2013) Bulking up on beta cells. N Engl J Med 369:777-779.
3. Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 153:747-758.
4. Zhang R, Abou-Samra AB (2013) Emerging roles of lipasin as a critical lipid regulator. Biochem Biophys Res Commun 432:401-405.
5. Fu Z, Yao F, Abou-Samra AB, Zhang R (2013) Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun 430:1126-1131.
6. Zhang R (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424:786-792.
7. Jiao Y, Le Lay J, Yu M, Naji A, Kaestner KH (2014) Elevated mouse hepatic betatrophin expression does not increase human b-cell replication in the transplant setting. Diabetes 63:1283-1288.
8. Gusarova V, Alexa CA, Na E, Stevis PE, Xin Y, et al. (2014) ANGPTL8/Betatrophin does not control pancreatic beta cell expansion. Cell 159:691-696.
9. Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, et al. (2014) Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 57:1204-1208.
10. Espes D, Lau J, Carlsson PO (2014) Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 57:50-53.
11. Espes D, Martinell M, Carlsson PO (2014) Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014:323-407.
12. Hu H, Sun W, Yu S, Hong X, Qian W, et al. (2014) Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 37:2718-2722.
13. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, et al. (2014) Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 4:5013.
14. Gómez-Ambrosi J, Pascual E, Catalán V, Rodríguez A, Ramírez B, et al. (2014) Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 99:E2004-2009.
15. Fu Z, Abou-Samra AB, Zhang R (2014) An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 57:2232-2234.
16. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, et al. (2010) Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 53:450-467. (In Japanese)
17. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982-992.
18. Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, et al. (2013) Mice lacking ANGPTL8 (betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 110:16109-16114.
19. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, et al. (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 109:19751 19756.
20. Zhang R, Abou-Samra AB (2014) A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol 13:133.
21. Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, et al. (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277:33742-33748.
22. Fujimoto K, Koishi R, Shimizugawa T, Ando Y (2006) Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 55:27-34.
23. Peloso GM, Auer PL, Bis JC, Voorman A, Morrison AC, et al. (2014) Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet 94:223-232.